1. P507 Efficacy of Infliximab after failure of subcutaneous anti-TNF agents in patients with moderate-to-severe ulcerative colitis. (25th January 2019) Authors: Viazis, N; Tsoukali, E; Galanopoulos, M; Pontas, C; Karampekos, G; Filippidis, G; Giouleme, O; Theocharis, G; Tzouvala, M; Archavlis, E; Christidou, A; Mantzaris, G J Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P659 Efficacy of switching from infliximab to golimumab in ulcerative colitis patients on deep remission. (25th January 2019) Authors: Viazis, N; Pontas, C; Gazouli, M; Tsigaridas, T; Tziortziotis, I; Chatzievangelinou, C; Gkeros, F; Vraka, M; Tsatsa, A; Tsoukali, E; Galanopoulos, M; Mantzaris, G J Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P750 Association between the use of antihypertensive agents and disease severity in patients with inflammatory bowel disease. (25th January 2019) Authors: Mantaka, A; Tsoukali, E; Fragaki, M; Karmiris, K; Viazis, N; Mantzaris, G; Koutroubakis, I Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗